| Company Name: |
Xi'an Confluore Biological Technology Co., Ltd.
|
| Tel: |
+86-156-80926068 +86-15680926068 |
| Email: |
1924344760@qq.com |
| Products Intro: |
Product Name:N-(DBCO-PEG4)-N-Biotin-PEG4-NHS CAS:2353409-72-8 Purity:>99.00% Package:25mg;50mg;100mg
|
N-(DBCO-PEG4)-N-Biotin-PEG4-NHS manufacturers
|
| | N-(DBCO-PEG4)-N-Biotin-PEG4-NHS Basic information |
| Product Name: | N-(DBCO-PEG4)-N-Biotin-PEG4-NHS | | Synonyms: | N-(DBCO-PEG4)-N-Biotin-PEG4-NHS;4,7,10,13,19,22,25,28-Octaoxa-16,31-diazapentatriacontanoic acid, 35-(11,12-didehydrodibenz[b,f]azocin-5(6H)-yl)-16-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-32,35-dioxo-, 2,5-dioxo-1-pyrrolidinyl ester;2,5-Dioxo-1-pyrrolidinyl 35-(11,12-didehydrodibenz[b,f]azocin-5(6H)-yl)-16-[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]-32,35-dioxo-4,7,10,13,19,22,25,28-octaoxa-16,31-diazapentatriacontanoate | | CAS: | 2353409-72-8 | | MF: | C54H74N6O16S | | MW: | 1095.26 | | EINECS: | | | Product Categories: | | | Mol File: | 2353409-72-8.mol |  |
| | N-(DBCO-PEG4)-N-Biotin-PEG4-NHS Chemical Properties |
| density | 1.33±0.1 g/cm3(Predicted) | | solubility | Soluble in Water, DCM, DMF | | pka | 13.90±0.40(Predicted) |
| | N-(DBCO-PEG4)-N-Biotin-PEG4-NHS Usage And Synthesis |
| Description | N-(DBCO-PEG4)-N-Biotin-PEG4-NHS is a click chemistry biotinylation reagent, NHS active esters can be used to label the primary amines (-NH2) of proteins and other amine-attached macromolecule. DBCO group is very reactive with azide molecule via copper-free Click Chemistry. | | Uses | N-(DBCO-PEG4)-N-Biotin-PEG4-NHS is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[1]. N-(DBCO-PEG4)-N-Biotin-PEG4-NHS is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups. | | IC 50 | PEGs | | References | [1] An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562 DOI:10.1016/j.ebiom.2018.09.005 |
| | N-(DBCO-PEG4)-N-Biotin-PEG4-NHS Preparation Products And Raw materials |
|